Predicting Treatment Response in Patients With HR-positive, HER2-negative Breast Cancer
Studies presented at the 2024 SABCS examined ways to predict responses to treatments for HR-positive, HER2-negative breast cancer.
Category: Meetings
Studies presented at the 2024 SABCS examined ways to predict responses to treatments for HR-positive, HER2-negative breast cancer.
Data from clinical trials presented at SABCS may help patients with DCIS make informed choices between different management...
New advances in our understanding of cancer cachexia may provide hope for patients with pancreatic cancer.
Susan Kaech and Ton Schumacher gave thought-provoking keynotes at the AACR Special Conference in Cancer Research: Tumor Immunology and...
The AACR Industry Roundtable 2024 focused on topics related to tracking and treating early cancers, including predicting cancer risk...
The 16th Frontiers in Cancer Science conference in Singapore includes a thematic focus on immuno-oncology, genomics, metabolism, and AI.
Changes to sexual health during breast cancer treatment can impact quality of life and treatment adherence—especially in Black women.
The AACR Special Conference: Liquid Biopsy features experts exploring all facets of this exciting technological arena.
Researchers are looking into urine tests that could detect cancers earlier, including lung, ovarian, pancreatic, colorectal, and more.
Melissa Davis, PhD, is putting health disparities under a lens. One that can take an aerial view of the...